These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

957 related articles for article (PubMed ID: 18022596)

  • 1. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.
    Komers R; Schutzer W; Xue H; Oyama TT; Lindsley JN; Anderson S
    Transl Res; 2007 Dec; 150(6):343-9. PubMed ID: 18022596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of flutamide on systemic and renal hemodynamics in Zucker diabetic rats: paradoxic renal vasodilator response to endothelin-1 and TXA2 receptor activation in female sex.
    Ajayi AA; Fidelis P
    J Cardiovasc Pharmacol; 2006 Nov; 48(5):191-8. PubMed ID: 17110800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of lovastatin on renal function and expression of phosphorylating-p38 mitogen-activated protein kinase in experimental diabetic nephropathy in rats].
    Wang LH; Duan HJ; Shi YH; Liu QJ; He N; Liu SX
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Dec; 16(12):734-7. PubMed ID: 15585148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of KATP channel blocker U37883A on renal function in experimental diabetes mellitus in rats.
    Vallon V; Albinus M; Blach D
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1215-21. PubMed ID: 9732381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.
    Georgescu A; Popov D; Dragan E; Dragomir E; Badila E
    Eur J Pharmacol; 2007 Sep; 570(1-3):149-58. PubMed ID: 17612521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of phosphorylation of p38 MAPK involved in the protection of nephropathy by emodin in diabetic rats.
    Wang J; Huang H; Liu P; Tang F; Qin J; Huang W; Chen F; Guo F; Liu W; Yang B
    Eur J Pharmacol; 2006 Dec; 553(1-3):297-303. PubMed ID: 17074319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal autoregulation and passive pressure-flow relationships in diabetes and hypertension.
    Hill JV; Findon G; Appelhoff RJ; Endre ZH
    Am J Physiol Renal Physiol; 2010 Oct; 299(4):F837-44. PubMed ID: 20660017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic inhibition of p38MAPK improves cardiac and endothelial function in experimental diabetes mellitus.
    Riad A; Unger D; Du J; Westermann D; Mohr Z; Sobirey M; Dorenkamp M; Schultheiss HP; Tschöpe C
    Eur J Pharmacol; 2007 Jan; 554(1):40-5. PubMed ID: 17097634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment.
    Pedersen MM; Christensen CK; Hansen KW; Christiansen JS; Mogensen CE
    Clin Invest Med; 1991 Dec; 14(6):642-51. PubMed ID: 1665407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 2. Improved renal function as assessed by dynamic contrast-enhanced magnetic resonance imaging.
    Lenhard SC; Nerurkar SS; Schaeffer TR; Mirabile RC; Boyce RW; Adams DF; Jucker BM; Willette RN
    J Pharmacol Exp Ther; 2003 Dec; 307(3):939-46. PubMed ID: 14561850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cyclooxygenase-2 (COX-2) inhibition on plasma and renal renin in diabetes.
    Komers R; Tian W; Lindsley JN; Oyama TT; Cohen DM; Anderson S
    J Lab Clin Med; 2002 Nov; 140(5):351-7. PubMed ID: 12434137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of protein kinase Cbeta protects against diabetes-induced impairment in arachidonic acid dilation of small coronary arteries.
    Zhou W; Wang XL; Lamping KG; Lee HC
    J Pharmacol Exp Ther; 2006 Oct; 319(1):199-207. PubMed ID: 16861398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotelemetric monitoring of blood pressure and mesenteric arterial bed responsiveness in rats with streptozotocin-induced diabetes.
    Tatchum-Talom R; Gopalakrishnan V; McNeill JR
    Can J Physiol Pharmacol; 2000 Sep; 78(9):721-8. PubMed ID: 11007535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction of nitrergic neurovascular dysfunction in diabetic mouse corpus cavernosum by p38 mitogen-activated protein kinase inhibition.
    Nangle MR; Cotter MA; Cameron NE
    Int J Impot Res; 2006; 18(3):258-63. PubMed ID: 16355109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
    Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
    Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy.
    Veelken R; Hilgers KF; Hartner A; Haas A; Böhmer KP; Sterzel RB
    J Am Soc Nephrol; 2000 Jan; 11(1):71-79. PubMed ID: 10616842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of angiotensin II on insulin receptor binding and mRNA levels in normal and diabetic rats.
    Sechi LA; Griffin CA; Zingaro L; Valentin JP; Bartoli E; Schambelan M
    Diabetologia; 1997 Jul; 40(7):770-7. PubMed ID: 9243097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of orchiectomy on renal function in control and diabetic rats with chronic inhibition of nitric oxide.
    Anderson S; Chapman JG; Oyama TT; Komers R
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):19-23. PubMed ID: 19473197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of angiotensin-converting enzyme inhibition in diabetic rats with reduced renal function.
    Geiger H; Bahner U; Vaaben W; Dammrich J; Heidland A; Luft FC
    J Lab Clin Med; 1992 Dec; 120(6):861-8. PubMed ID: 1453108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.